Search

From formerly unknown diseases to conquered diseases, a medical revolution is underway and victories are multiplying.

Find here information on diseases : advances of research booklets presenting the lastest information on a given disease or group of diseases, information on trials and access to the Myobase portal. 

AFM-Telethon has long struggled to defend the rights of patients, of people living with disabilities, and to obtain recognition for rare diseases. As a driver of research and innovation, it defends an ambitious national policy.  

The AFM-Telethon has chosen to implement a strategy of public interest to benefit as many people as possible.  

While the first gene therapy drugs are obtaining marketing authorization and being made available to patients, the challenge of industrializing their production is a crucial one.

Peeling an apple. Lifting your arms. Walking. Smiling. Breathing. These routine actions use muscles and we accomplish them without thinking. But with neuromuscular diseases, the muscles are attacked and movement is prevented. In order to better treat them, AFM-Telethon wants to make myology a separate discipline. 

Participation in the Telethon or support for our therapeutic and social innovation projects, your company can get involved in various ways. Find out how to become a partner/sponsor of AFM-Telethon.

The French Telethon also takes place abroad. French expatriates can join in this 30-hour marathon of celebration and solidarity from all over the world. You live abroad and want to be part of the great Telethon adventure? Join us!  

You can pass on not only your genes It is above all about deep convictions, to last beyond your lifetime.  

Gene, cellular and pharmacogenetic therapy: AFM-Telethon uses donations to develop new therapies for the most frequent rare diseases.   

AFM-Telethon puts the power of patients at the core of its international activities, with the aim of strengthening the place of French neuromuscular patients in Europe and in the world. 

Innovative therapies for rare diseases are being developed internationally. Base on this observation, AFM-Telethon encourages worldwide collaboration between the most competent teams.

Find here all the latest news on AFM-Telethon and rare diseases.

Find here AFM-Telethon's latest news, publications and press releases.

AFM-Telethon takes action in various fields, from research, development and bioproduction of innovative therapies for rare diseases to care for patients and their relatives. The association also advocates to defend patients’ rights and takes part in international activities. Discover our actions to fight disease.